[On Demand]
ReiThera is a biotech company dedicated to the development, GMP manufacturing and clinical translation of genetic vaccines and medicinal products for advanced therapies. The company has a long-standing expertise in the development of scalable processes for viral vector manufacturing, supported by a cGMP facility inclusive of filling suite and quality control laboratories.
ReIthera has a business model which includes the development of an internal pipeline (Vaccine against COVID 19) and also operate as CDMO offering process development and GMP production services.
ReiThara bases its core capacity in a state-of-the-art facility including stirred-tank bioreactors supporting a working volume at the scale of 200L, 1000L and 2000L for production in suspension and fixed bed bioreactors for adherent growth of the cell substrate.
ReiThera is welcome to meet company interested in exploring the possibility of performing process development and GMP production at ReiThe
Company Type:
Privately Funded Company
Company Website:
Company HQ State:
Not Provided
Company HQ Country:
Year Founded:
Main Therapeutic Focus:
Lead Product in Development:
GRAd-CON2 vaccine, a vaccine against covid 19
Development Phase of Primary Product:
Number Of Unlicensed Products (For Which You Are Seeking Partners):
Head of Business Development
ReiThera Srl